This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

ISIS-SGLT2Rx

Ionis Pharmaceuticals, Inc.

Drug Names(s): ISIS 388626

Description: ISIS 388626 is an antisense drug that inhibits the production of sodium dependent glucose co-transporter type 2 (SGLT2). Because SGLT2 is responsible for glucose re-absorption in the kidney, blocking that action promotes glucose excretion and lowers blood sugar.


ISIS-SGLT2Rx News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug